×

Our award-winning reporting has moved

Context provides news and analysis on three of the world’s most critical issues:

climate change, the impact of technology on society, and inclusive economies.

BRIEF-CEPI Says Partnered With BioNet To Expand Variant-Proof Vaccine Programme

by Reuters
Tuesday, 25 January 2022 09:37 GMT

Jan 25 (Reuters) -

* CEPI PARTNERS WITH BIONET TO EXPAND VARIANT-PROOF VACCINE PROGRAMME - STATEMENT

* COALITION FOR EPIDEMIC PREPAREDNESS - TO PROVIDE UP TO $16.9 MILLION TO BIONET TO SUPPORT PRECLINICAL STUDIES, PHASE I & II TRIALS, OTHER DEVELOPMENTS

Our Standards: The Thomson Reuters Trust Principles.


-->